Posted by Michael Wonder on 02 Sep 2020
23 attorneys general urge FDA to ensure affordable access to insulin
3 September 2020 - Michigan Attorney General Dana Nessel has joined a bipartisan coalition of 23 attorneys general in signing a letter urging the FDA to prohibit use of the publication “Approved Drug Products with Therapeutic Equivalence Evaluation” – commonly known as the Orange Book – to block competition.
The Orange Book enables branded drug manufacturers to obtain an automatic 30 month suspension of the FDA’s approval of any potential generic competitor claiming a listed patent.
